Pharmaceutical marketing: the example of drug samples

References

• Brown SR. Physicians should refuse pharmaceutical industry gifts. Am Fam Physician. 2021;104(4):348–350.
   PubMed Web of Science ®Google Scholar
• Dewatripont M, Goldman M. Free drug samples and the opioid crisis. N Engl J Med. 2018;379(8):793–794. https://doi.org/10.1056/NEJMc1805809.
   PubMed Web of Science ®Google Scholar
• Katz KA, Reid EE, Chren MM. Drug samples in dermatology: out of the closet, into the dustbin. JAMA Dermatol. 2014;150(5):483–485. https://doi.org/10.1001/jamadermatol.2013.9711.
   PubMed Web of Science ®Google Scholar
• Tran LL. Drug samples: why not? Virtual Mentor VM. 2014;16(4):245–251. https://doi.org/10.1001/virtualmentor.2014.16.04.ecas2-1404.
   PubMedGoogle Scholar
• Wendling P. Physicians are split on the ethics of free drug samples. Cardiology News. Published March 1, 2007. Accessed 6 Jan 2022. https://www.mdedge.com/cardiology/article/42327/health-policy/physicians-are-split-ethics-free-drug-samples.
   Google Scholar
• Dong X, Li M, Xie Y. Understanding Sample Usage and Sampling as a Promotion Tool: State of Industry Practice and Current Research. In: Ding M, Eliashberg J, Stremersch S, editors. Innovation and Marketing in the Pharmaceutical Industry: Emerging Practices, Research, and Policies. International Series in Quantitative Marketing. New York: Springer; 2014. p. 507–530.
   Google Scholar
• Joseph K, Mantrala M. A model of the role of free drug samples in physicians’ prescription decisions. Mark Lett. 2009;20(1):15–29.
   Web of Science ®Google Scholar
• Schwartz LM, Woloshin S. Medical Marketing in the United States, 1997–2016. JAMA. 2019;321(1):80–96. https://doi.org/10.1001/jama.2018.19320.
   PubMed Web of Science ®Google Scholar
• Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician–industry relationships. N Engl J Med. 2007;356(17):1742–1750. 10.1056/NEJMsa064508.
   PubMed Web of Science ®Google Scholar
• Lessard A, Lussier MT, Diallo FB, et al. Drug samples in family medicine teaching units: a cross-sectional descriptive study. Can Fam Physician. 2018;64(12):e540–e545.
   PubMedGoogle Scholar
• Hurley MP, Stafford RS, Lane AT. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea. JAMA Dermatol. 2014;150(5):487–493. https://doi.org/10.1001/jamadermatol.2013.9715.
   PubMed Web of Science ®Google Scholar
• Groves KEM, Sketris I, Tett SR. Prescription drug samples – does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther. 2003;28:259–271.
   PubMed Web of Science ®Google Scholar
• Federal Trade Commission. A Review of Food Marketing to Children and Adolescents; 2012.
   Google Scholar
• Li H, Jain S, Kannan PK. Optimal design of free samples for digital products and services. J Mark Res. 2019;56(3):419–438. https://doi.org/10.1177/0022243718823169.
   Web of Science ®Google Scholar
• Scott CA. The effects of trial and incentives on repeat purchase behavior. J Mark Res. 1976;13(3):263–269. https://doi.org/10.1177/002224377601300307.
   Web of Science ®Google Scholar
• Shiv B, Nowlis SM. The effect of distractions while tasting a food sample: the interplay of informational and affective components in subsequent choice. J Consum Res. 2004;31(3):599–608. https://doi.org/10.1086/425095.
   Web of Science ®Google Scholar
• Gedenk K, Neslin S. The role of retail promotion in determining future brand loyalty: its effect on purchase event feedback. Published Online. 1999. https://doi.org/10.1016/S0022-4359(99)00018-4.
   Google Scholar
• Chandukala SR, Dotson JP, Liu Q. An assessment of when, where and under what conditions in-store sampling is most effective. J Retail. 2017;93(4):493–506. https://doi.org/10.1016/j.jretai.2017.07.002.
   Web of Science ®Google Scholar
• Bawa K, Shoemaker R. The effects of free sample promotions on incremental brand sales. Mark Sci. 2004;23(3):345–363.
   Web of Science ®Google Scholar
• Gönül FF, Carter F, Petrova E, Srinivasan K. Promotion of prescription drugs and its impact on physicians’ choice behavior. J Mark. 2001;65(3):79–90.
   Web of Science ®Google Scholar
• Brown BP, Bellenger DN, Johnston WJ. The Implications of business-to-business and consumer market differences for B2B branding strategy. J Bus Mark Manag. 2007;1(3):209–230. https://doi.org/10.1007/s12087-007-0011-x.
   Google Scholar
• Gaedeke RM, Tootelian DH, Sanders EE. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives. Health Mark Q. 1999;17:23–31.
   PubMedGoogle Scholar
• Montoya R, Netzer O, Jedidi K. Dynamic allocation of pharmaceutical detailing and sampling for long-term profitability. Mark Sci. 2010;29(5):909–924.
   Web of Science ®Google Scholar
• Venkataraman S, Stremersch S. The debate on influencing doctors’ decisions: are drug characteristics the missing link? Manag Sci. 2007;53(11):1688–1701.
   Web of Science ®Google Scholar
• Bala R, Bhardwaj P, Chen Y. Offering pharmaceutical samples: the role of physician learning and patient payment ability. Mark Sci. 2013;32(3):522–527. https://doi.org/10.1287/mksc.1120.0743.
   Web of Science ®Google Scholar
• Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. 2007;4(4): e150. https://doi.org/10.1371/journal.pmed.0040150.
   PubMed Web of Science ®Google Scholar
• Neslin S. ROI analysis of pharmaceutical promotion (RAPP): An independent study. Accessed 22 May 2001.
   Google Scholar
• Chew LD, O’Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians’ behavior. J Gen Intern Med. 2000;15(7):478–483. https://doi.org/10.1046/j.1525-1497.2000.08014.x.
   PubMed Web of Science ®Google Scholar
• Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract. 2000;49(9):811–816.
   PubMed Web of Science ®Google Scholar
• Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA. 1997;278(2):141–143.
   PubMed Web of Science ®Google Scholar
• Morelli D, Koenigsberg MR. Sample medication dispensing in a residency practice. J Fam Pract. 1992;34(1):42–48.
   PubMed Web of Science ®Google Scholar
• Weinstein D. Samples no longer hold sway in pharma marketing mix: study. MM+M - Medical Marketing and Media. Published February 21, 2012. Accessed 6 Jan 2022. https://www.mmm-online.com/home/channel/samples-no-longer-hold-sway-in-pharma-marketing-mix-study/.
   Google Scholar
• Adair R. Hidden costs of free samples. AMA J Ethics. 2006;8(6):367–371. https://doi.org/10.1001/virtualmentor.2006.8.6.ccas2-0606.
   Google Scholar
• Alexander GC, Zhang J, Basu A. Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care. 2008;46(4):394–402. https://doi.org/10.1097/MLR.0b013e3181618ee0.
   PubMed Web of Science ®Google Scholar
• Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23. https://doi.org/10.1016/j.amjopharm.2011.02.004.
   PubMed Web of Science ®Google Scholar
• Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: a nationally representative analysis. Am J Public Health. 2008;98(2):284–289. https://doi.org/10.2105/AJPH.2007.114249.
   PubMed Web of Science ®Google Scholar
• Stevens D, Sharma K, Kesten S. Insurance status and patient behavior with asthma medications. J Asthma Off J Assoc Care Asthma. 2003;40(7):789–793. https://doi.org/10.1081/jas-120023570.
   PubMed Web of Science ®Google Scholar
• Taira DA, Iwane KA, Chung RS. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. Am J Manag Care. 2003;9(4):305–312.
   PubMed Web of Science ®Google Scholar
• Manchanda P, Rossi PE, Chintagunta PK. Response modeling with nonrandom marketing-mix variables. J Mark Res. 2004;41(4):467–478.
   Web of Science ®Google Scholar
• Manchanda P, Xie Y, Youn N. The role of targeted communication and contagion in product adoption. Mark Sci. 2008;27(6):961–976.
   Web of Science ®Google Scholar
• Mizik N, Jacobson R. Are physicians “Easy Marks”? Quantifying the effects of detailing and sampling on new prescriptions. Manag Sci. 2004. https://doi.org/10.1287/mnsc.1040.0281.
   Web of Science ®Google Scholar
• Brax H, Fadlallah R, Al-Khaled L, et al. Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PLoS ONE. 2017;12(4): e0175493. https://doi.org/10.1371/journal.pone.0175493.
   PubMed Web of Science ®Google Scholar
• Keys T, Ryan MH, Dobie S, Satin D, Evans DV. Premedical student exposure to pharmaceutical marketing: too much, too soon? Fam Med. 2019;51(9):722–727. https://doi.org/10.22454/FamMed.2019.360469.
   PubMed Web of Science ®Google Scholar
• Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118(8):881–884. https://doi.org/10.1016/j.amjmed.2005.02.031.
   PubMed Web of Science ®Google Scholar
• Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med. 2002;34(10):729–731.
   PubMed Web of Science ®Google Scholar
• Pinckney RG, Helminski AS, Kennedy AG, Maclean CD, Hurowitz L, Cote E. The effect of medication samples on self-reported prescribing practices: a statewide, cross-sectional survey. J Gen Intern Med. 2011;26(1):40–44. https://doi.org/10.1007/s11606-010-1483-x.
   PubMed Web of Science ®Google Scholar
• Symm B, Averitt M, Forjuoh SN, Preece C. Effects of using free sample medications on the prescribing practices of family physicians. J Am Board Fam Med. 2006;19(5):443–449. https://doi.org/10.3122/jabfm.19.5.443.
   PubMed Web of Science ®Google Scholar
• Katz D, Caplan AL, Merz JF. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth AJOB. 2010;10(10):11–17. https://doi.org/10.1080/15265161.2010.519226.
   PubMed Web of Science ®Google Scholar
• Morgan MA, Dana J, Loewenstein G, Zinberg S, Schulkin J. Interactions of doctors with the pharmaceutical industry. J Med Ethics. 2006;32(10):559–563. 10.1136/jme.2005.014480.
   PubMed Web of Science ®Google Scholar
• Funk MJ, Landi SN. Misclassification in administrative claims data: quantifying the impact on treatment effect estimates. Curr Epidemiol Rep. 2014;1(4):175–185. https://doi.org/10.1007/s40471-014-0027-z.
   PubMedGoogle Scholar
• Chimonas S, Kassirer JP. No more free drug samples? PLoS Med. 2009;6(5): e1000074. https://doi.org/10.1371/journal.pmed.1000074.
   PubMed Web of Science ®Google Scholar
• Brown JD. Higher insulin expenditures associated with utilization of free medication samples. Res Soc Adm Pharm RSAP. 2020;16(9):1302–1305. https://doi.org/10.1016/j.sapharm.2019.04.001.
   PubMed Web of Science ®Google Scholar
• Pringle JL, Aldridge A, Kearney SM, et al. Evaluating the impact of sample medication on subsequent patient adherence. J Manag Care Spec Pharm. 2016;22(11):1262–1269. https://doi.org/10.18553/jmcp.2016.22.11.1262.
   PubMed Web of Science ®Google Scholar
• Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332–337. https://doi.org/10.1001/archinte.166.3.332.
   PubMed Web of Science ®Google Scholar
• Scott AB, Culley EJ, O’Donnell J. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization. J Manag Care Pharm JMCP. 2007;13(5):412–419. https://doi.org/10.18553/jmcp.2007.13.5.412.
   PubMed Web of Science ®Google Scholar
• Galt KA, Rule AM, Clark BE, Bramble JD, Taylor W, Moores KG. Best Practices in Medication Safety: Areas for Improvement in the Primary Care Physician’s Office. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation (Volume 1: Research Findings). Advances in Patient Safety. Agency for Healthcare Research and Quality (US); 2005. Accessed 6 Jan 2022.
   Google Scholar
• Poser S. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Food Drug Law J. 2007;62(4):653–694.
   PubMed Web of Science ®Google Scholar
• Pai MP, Graci DM, Bertino JS. Waste generation of drug product samples versus prescriptions obtained through pharmacy dispensing. Pharmacotherapy. 2000;20(5):593–595. https://doi.org/10.1592/phco.20.6.593.35155.
   PubMed Web of Science ®Google Scholar
• Charatan F. Hospital bans free drug samples. West J Med. 2001;174(4):236–237. https://doi.org/10.1136/ewjm.174.4.236-a.
   PubMedGoogle Scholar
• Brown SR. Closing the sample closet. Fam Pract Manag. 2006;13(10):16–21.
   PubMedGoogle Scholar
• Boyle T. Toronto doctors say no to free samples from drug firms. Toronto Star. Published October 26, 2013. Accessed 27 Oct 2022. https://www.thestar.com/news/gta/2013/10/26/toronto_doctors_say_no_to_free_samples_from_drug_firms.html#:~:text=A%20group%20of%20Toronto%20family,Michael’s%20Hospital%20clinic.&text=Dr.,drugs%20into%20two%20garbage%20bags.
   Google Scholar
• AMA Council on Ethical and Judicial Affairs. AMA code of medical ethics’ opinions on physicians’ relationships with drug companies and duty to assist in containing drug costs. AMA J Ethics. 2014;16(4):261–264. https://doi.org/10.1001/virtualmentor.2014.16.4.coet2-1404.
   Google Scholar
• Center for Drug Evaluation and Research. Temporary Policy on Prescription Drug Marketing Act Requirements for Distribution of Drug Samples During the COVID-19 Public Health Emergency. U.S. Food and Drug Administration. Published June 8, 2020. Accessed 5 Jan 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/temporary-policy-prescription-drug-marketing-act-requirements-distribution-drug-samples-during-covid.
   Google Scholar